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Rats subjected to bilateral common carotid artery (CCA) occlusion or 2-vessel occlusion 
(2VO) have been used as animal models of subcortical ischemic vascular dementia. However, 
this model possesses an inherent limitation in that cerebral blood flow (CBF) drops too sharply 
and substantially after ligation of CCAs. To circumvent such hypoxic-ischemic conditions, we 
tested to implant the ameroid constrictor device on bilateral CCAs of male Wistar-Kyoto rats 
and more precisely replicated chronic cerebral hypoperfusion by gradual narrowing of the CCAs 
(2-vessel gradual occlusion; 2VGO). The acute CBF reduction and resultant inflammatory 
responses observed in the 2VO rats were eliminated in the 2VGO rats. Thus, chronic cerebral 
hypoperfusion was segregated, and induced selective white matter changes with relatively 
preserved neurovascular coupling and substantially less metabolic and histological 
derangements in the gray matter including the hippocampus. This led to significant spatial 
working memory impairment of a similar magnitude to the 2VO rats at 28 days post-operation. 
The 2VGO model may more closely mimic cognitive impairment subsequent to selective white 
matter damage. 
 
Keywords: Vascular dementia; Chronic cerebral hypoperfusion; Ameroid constrictor; White 
matter change; Rat; Neurovascular coupling 
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1. Introduction 
Vascular dementia (VaD) is the second most common cause of dementing illnesses after 
Alzheimer’s disease (AD). Approximately half of all cases of VaD are explained by subcortical 
ischemic vascular dementia (SIVD) (Yoshitake et al., 1995), which is characterized by lacunar 
infarctions in the basal ganglia and ischemic white matter changes. Loss of vasomotor reactivity 
in the small vessels and resultant chronic cerebral hypoperfusion with blood-brain barrier 
(BBB) disruption and glial activation may underlie the white matter changes (Marshall and 
Lazar, 2011; Pantoni, 2010). 
To mimic such a pathological condition and explore the underlying mechanisms, several 
animal models of chronic cerebral hypoperfusion have been developed, including bilateral 
common carotid artery (CCA) or 2-vessel occlusion (2VO) in rats, bilateral CCA stenosis in 
gerbils or mice (BCAS) (Shibata et al., 2004) and unilateral CCA occlusion in mice (Yoshizaki 
et al., 2008). Among these, the rat 2VO model has been frequently used (Jiwa et al., 2010) and 
may become more important once genetically-modified rats are widely available. The 2VO 
model exhibits characteristic features of SIVD, such as white matter damage (Wakita et al., 
1994; Wakita et al., 2002), and cognitive impairment (Farkas et al., 2007; Hainsworth and 
Markus, 2008; Jiwa et al., 2010). Nevertheless, this model possesses an inherent limitation in 
that cerebral blood flow (CBF) drops too sharply and substantially after the ligation of the 
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CCAs and remains too low (30–45% of the baseline level) for 2–3 days; this therefore creates 
hypoxic-ischemic conditions too severe to replicate ‘chronic’ cerebral hypoperfusion (Marosi et 
al., 2006). Following this acute phase, CBF gradually recovers but still remains relatively low 
(50–90%) for 8 weeks to 3 months post-operation (chronic phase) (Otori et al., 2003; Tomimoto 
et al., 2003). Although the sustained oligemia in the chronic phase is believed to better replicate 
chronic cerebral hypoperfusion associated with SIVD, the contribution of the preceding acute 
phase to the neuropathological and behavioral consequences is an ongoing concern (Farkas et al., 
2007). We therefore sought to establish a novel rat model that eliminates the acute phase, 
meaning that CBF would gradually decrease to the level in the chronic phase, using the ameroid 
constrictor device. This device could predictably achieve gradual narrowing of the CCAs and 
establish a rat model of SIVD that replicates ‘chronic’ cerebral hypoperfusion more precisely. 
We therefore henceforth refer to this novel rat model as the ‘2-vessel gradual occlusion 
(2VGO)’ model. 
 
2. Materials and Methods 
2. 1. Animals 
We used 12- to 14-week-old male Wistar-Kyoto rats (WKY) (See Supplemental Method I 
for details). 
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2. 2. Ameroid constrictor 
The ameroid constrictor (Research Instruments NW, OR, USA) consists of a stainless steel 
casing surrounding a hygroscopic casein material that has an internal lumen. The casein 
component gradually absorbs water and consequently swells, leading to predictable narrowing 
and occlusion of the arterial lumen that it encases (Fig. 1A, B and C). The inner diameter was 
0.5 mm, the outer diameter 3.25 mm and the length 1.28 mm. 
2. 3. Study design 
WKY rats were divided into three groups: 2-vessel gradual occlusion (2VGO), 2-vessel 
occlusion (2VO) and sham control groups (Supplemental Method II). Temporal changes of 
blood flow in the CCAs were recorded by computed tomography-angiography (CTA); the CBF 
in the frontal cortices was measured by laser speckle flowmetry (LSF; Omega Zone; 
Omegawave, Tokyo, Japan), and 
18
F-Fluorodeoxyglucose (FDG) positron emission tomography 
(PET) imaging was performed at indicated time points. Histological evaluation of 
demyelinating changes and glial activation, analysis of cerebral mRNA and protein levels of 
inflammatory cytokines and Western blotting analysis of myelin basic protein (MBP) were 
performed at indicated points. Spatial working memory was assessed by the Y-maze test (Fig. 
2).  
2. 4. Surgical procedure 
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Under anesthesia, the 2VGO rats were subjected to surgical implantation of ameroid 
constrictors on the CCAs bilaterally whereas in the 2VO group, both the CCAs were ligated  
(Supplemental Method III). 
2. 5. Computed tomography-angiography 
CTA of the bilateral CCAs was repeatedly performed under
 
anesthesia using the R_mCT 
system (Rigaku, Tokyo, Japan) (Supplemental Method IV). 
2. 6. Cerebral blood flow, blood pressure and pulse rate measurement 
CBF in the frontal cortices was recorded
 
by LSF under anesthesia with isoflurane (1.5%) 
(Supplemental Method V). 
2. 7. 
18
F-FDG PET acquisition and image analysis 
Small animal PET imaging was performed to assess temporal changes in 
18
F-FDG uptake 
during the first 5 minutes and again between 45 and 90 minutes (Supplemental Method VI). 
2. 8. Histological evaluation of demyelinating changes and glial activation 
Paraffin-embedded coronal sections of the brain (6 μm-thick) were analyzed with 
hematoxylin-eosin (HE) staining for detection of infarcted areas in the forebrain and for 
neurodegeneration in the hippocampal CA1 and CA3 regions, and with
 
Klüver-Barrera staining 
for demyelinating changes. The severity of the white matter lesions in the optic chiasma, medial 
and lateral parts of the corpus callosum and caudoputamen, was graded
 
as normal (Grade 0), 
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disarrangement of the nerve fibers (Grade
 
1), the formation of marked vacuoles (Grade 2) and 
the disappearance
 
of myelinated fibers (Grade 3), according to the established criteria (Wakita et 
al., 1994). They were also immunostained for ionized calcium binding
 
adaptor molecule-1 
(Iba-1; a marker of microglia; Wako, Osaka, Japan), glial fibrillary
 
acidic protein (GFAP; 
astrocyte; DAKO, Glostrup, Denmark), glutathione S-transferase-π (GST-π; oligodendrocyte; 
Assay Designs, Ann Arbor, MI, USA), degraded MBP (dMBP; demyelinating changes; a gift 
from Dr. Wakita) (Ihara et al., 2010) and myelin-associated glycoprotein (MAG; Santa Cruz 
Biotechnology, CA, USA) (Supplemental Method VII). 
2. 9. Quantitative real-time reverse transcriptase–polymerase chain reaction 
Cerebral mRNA levels of the monocyte chemoattractant protein-1 (MCP-1)
 
and tumor 
necrosis factor-α (TNF-α) were assessed by quantitative real-time RT-PCR (Supplemental 
Method VIII). 
2. 10 Enzyme-Linked Immunosorbent Assay (ELISA) for TNF-α 
The protein concentration of TNF-α in brain homogenates were also measured using a 
specific ELISA kit according to the manufacturer’s recommendation (R&D systems, 
Minneapolis, MN, USA) (Supplemental Method IX). 
2. 11. Western blotting analysis for myelin basic protein 
The optic nerves and chiasma were analyzed for demyelinating changes. A rabbit anti-MBP 
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antibody and a mouse anti β-actin antibody (which served as an internal control), were used 
(Supplemental Method X). 
2. 12. Y-maze test for spatial working memory assessment 
Spatial working memory was assessed by the Y-maze test (Supplemental Method XI). 
2. 13. Statistical analysis 
All values are expressed as mean±SEM. One-way analysis of variance was used to 
evaluate significant
 
differences among groups (except where otherwise stated) followed by a 
post hoc Tukey
 
test or Tukey-Kramer test. Differences with P<0.05
 







3. 1. Mortality rates and body weight changes of rats 
The mortality rate in the 2VGO group was 2.0% (1/49). This was much lower than that of 
the 2VO group, which was 13.8% (8/58), in accordance with previous reports (Fujishima et al., 
1976). In the sham group, all of 48 rats survived until euthanized. Body weight decreased in 
both the 2VGO and 2VO groups, which was significantly less severe in the 2VGO group at 1 
day post-operation (2VGO group, -14.1±2.0% vs. 2VO group, -27.4±1.7%; P<0.01). Both 
groups of rats started to regain body weight at 3 days.  
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3. 2. Gradual narrowing of the common carotid arteries 
Bilateral placement of the ameroid constrictors on the CCAs produced the expected 
narrowing of the inner lumen: 0.28 mm at 1 day post-operation, 0.24 mm at 3 days and 0.19 mm 
at 5 days (Fig. 1B and C). CTA indicated that blood flow of CCAs distal to the implanted 
ameroid constrictors did not decrease at 1 hour but started to decrease at 3 hours, leading to 
complete occlusion of the CCAs at 3 days (Fig. 3). 
3. 3. Temporal profiles of CBF recorded by LSF 
In the 2VO group, CBF dropped sharply to 55.2±0.8% of the baseline level at 3 hours 
post-operation but started to recover at 3 days and reached to 85.6±3.7% at 28 days. In contrast, 
in the 2VGO group, the acute phase observed in the 2VO group was absent; CBF did not 
decrease at 1 hour (102.5±2.9%) but started to decrease at 3 hours (79.6±3.3%), and reached a 
minimum at 3 days (69.3±1.7%), before gradually recovering at 28 days (84.5±3.3%). In the 
sham group, no apparent change of CBF was detected. Two-way repeated-measures analysis of 
variance showed a significant interaction between group and time (F(14, 63)=16.976, P<0.001) 
and significant differences between the 2VGO and 2VO groups at 1, 3 and 6 hours and 1 day 
(Fig. 4A and B). 
 The blood pressure and pulse rate of the surviving rats did not differ significantly among 




F-FDG PET analysis 
The first 5-minute uptake of 
18
F-FDG, which was used as an indicator of CBF, showed a 
similar temporal profile of the CBF recorded
 
by LSF: the uptake dropped more substantially in 
the 2VO than 2VGO groups at 3 hours post-operation but recovered at 28 days in the both 
groups (Fig. 5A). 
The late 
18
F-FDG uptake, used as an indicator of cerebral glucose metabolism, did not 
significantly decrease at 28 days in the 2VGO group. Whereas, in the 2VO group at 28 days, 
late 
18
F-FDG uptake significantly decreased in the cerebral cortex compared to that in the 
2VGO group and in the hippocampus compared to pre-operation (Fig. 5B). 
3. 5. Y-maze test for spatial working memory assessment 
In the 2VGO and 2VO groups, the percentage of alternation behaviors (used as a reflection 
of spatial working memory) was significantly decreased (Fig. 6A), whereas the number of arm 
entries was significantly increased, compared with the sham group at 28 days (Fig. 6B). 
3. 6. Histological analysis of gray matter damage 
Brain infarcted areas were not found in any rats of the 2VGO and sham groups but in 50% 
of rats in the 2VO group at 3, 14 and 28 days (Supplemental Fig. 1A). The infarctions were 
distributed mainly in the caudoputamen. Cortical gliosis was not found in the sham group and 
was present in only 8.3% of rats in the 2VGO group at 3, 14 and 28 days (Supplemental Fig. 
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1B); however, cortical gliosis was present in 75% of rats in the 2VO group over the same 
periods. There was a trend toward increased density of pyknotic neurons in the hippocampal 
CA1 region at 28 days in the 2VO group compared to the 2VGO and sham groups 
(Supplemental Fig. 1C); however, there were no significant differences in density among the 
three groups. 
3. 7. Histological analysis of white matter damage 
Quantitative analysis of the grading score of Klüver-Barrera staining of the corpus 
callosum indicated that the white matter damage was significantly more severe in both the 
2VGO and 2VO groups compared with the sham group at 28 days post-operation; however, the 
extent of damage was significantly smaller in the 2VGO compared to 2VO groups (Fig. 7A). 
Similar findings in the degree of myelin damage (assessed by dMBP staining) (Fig. 7B) and the 
density of GST-π-positive oligodendrocytes (Fig. 7C) were discovered: the white matter damage 
was slightly milder in the 2VGO compared to the 2VO groups but was still more severe than the 
sham group. In the 2VGO and 2VO groups, MAG-immunopositive regions (indicating the 
degree of axon-glial integrity) decreased compared to the sham group, with the most apparent 
difference at 28 days (data not shown). The density of GFAP-immunopositive astrocytes was 
significantly greater in both the 2VGO and 2VO groups compared to the sham group at 28 days 
(data not shown). The density of Iba-1-immunopositive microglia increased from 1 day in the 
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2VO group; while in the 2VGO group, there was no change in microglia density at 1 day but an 
increase at 3 days. The microglial density in both the 2VGO and 2VO groups remained 
significantly greater than the sham group at 28 days (Supplemental Fig. 2A and B). 
3. 8. Western blotting analysis for MBP at 28 days post-operation 
In addition to dMBP immunohistochemistry, MBP immunoblotting was evaluated as a 
marker of white matter integrity. Western blotting for MBP at 28 days showed multiple bands 
corresponding to the four isoforms (21.5/18.5/17/14 kDa). Densitometric analyses showed 
significant reduction in those bands both in the 2VGO and 2VO groups compared to the sham 
group. However, the reduction was less substantial in the 2VGO than 2VO groups (Fig. 8). 
3. 9. mRNA expression of inflammatory cytokines at 1 day post-operation 
At 1 day, cerebral mRNA expression of inflammatory cytokines, MCP-1 and TNF-α, was 
significantly increased in the 2VO group but slightly increased in the 2VGO group compared to 
the sham group (Fig. 9A and B). 
3. 10. The protein level of TNF-α at 1 day post-operation. 
At 1 day, cerebral protein level of TNF-α was significantly increased in both the 2VGO 





The findings in this study suggest circumvention of the acute phase of CBF reduction and 
resultant acute inflammatory response observed in the 2VO model by gradual narrowing of the 
bilateral CCAs using the ameroid constrictor device instead of ligation. As a result, segregation 
of the chronic phase from the acute phase was achieved, suggesting a more precise 
reconstruction of chronic cerebral hypoperfusion evident in clinical cases of SIVD. This method 
induced demyelinating changes with inflammatory and glial responses but without apparent 
infarcted lesions or pronounced metabolic derangement in the gray matter. White matter 
changes were substantial in both the 2VGO and 2VO groups but significantly less severe in the 
2VGO group. This suggests that the neuropathological consequences and metabolic changes of 
the 2VO model had been generated not only by chronic cerebral hypoperfusion but also by 
acute drop in CBF immediately after bilateral CCAs occlusion. The differences in mortality rate, 
infarction rate and body weight loss between the 2VGO and 2VO groups may reflect gradual 
CBF reduction in the 2VGO group. 
Y-maze tests showed significant spatial working memory impairment in both the 2VGO 
and 2VO groups. The spatial working memory impairment in the 2VGO model may be derived 
from white matter damage because neuropathological changes and glucose hypometabolism 
were not apparent in the cortex and hippocampus at 28 days. By contrast, the 2VO model 
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exhibited persistent metabolic derangement in the gray matter at 28 days, despite CBF recovery; 
this suggests neurovascular uncoupling even at 28 days post-operation. The 2VO and 2VGO 
model may thus be defined by the presence or absence of the acute CBF drop, respectively; 
therefore, the persistent neurovascular uncoupling at 28 days in the 2VO group may result from 
the ischemic insult applied to the brain in the acute phase post-operation. These results therefore 
suggest that the 2VGO model may more closely replicate the condition of working memory 
impairment subsequent to ischemic white matter changes. 
The reasons as to why the 2VGO model showed comparable spatial working memory 
impairment to the 2VO model may be explained by the fact that less pronounced white matter 
damage was sustained in the 2VGO model compared to the 2VO model where the damage was 
sufficient to induce spatial working memory impairment detected by the Y-maze test. Another 
reason may be the impaired glial-axon integrity (assessed with MAG immunostaining) (Quarles, 
2007), which was comparable between 2VGO and 2VO models; this therefore may have 
contributed to the working memory impairment. 
No single animal model appears to recapitulate all the features of SIVD as humans have 
different brain anatomy and longer perforating arteries. In addition, the current model lacks 
vascular risk factors and causative small vessel changes that may lead to alterations in blood 
flow and cerebral autoregulation. One of the ways to resolve this problem could be to implant 
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ameroid constrictors in spontaneous hypertensive rats (SHR). However, SHRs subjected to the 
bilateral CCA occlusion have shown more extensive CBF reduction accompanied by more 
extensive cerebral infarcts and demyelinating changes and higher mortality rate (72%; 78 of 
108) than the corresponding normotensive counterpart WKY rats (16%; 7 of 43) (Fujishima et 
al., 1976; Ogata et al., 1976). Beside the high mortality, such severe CBF reduction with marked 
infarctions may not adequately represent SIVD. Our preliminary data showed that the mortality 
rate of SHRs subjected to implantation of ameroid constrictors to the bilateral CCAs was only 
6.2% (1 of 16) (Kitamura, unpublished data). Therefore, comparison of the effects of 2VGO on 
SHRs and on WKY rats could facilitate our understanding of the clinical and pathological 
substrates of SIVD with small vessel pathology, with the caveat that the genetic background of 
SHR is not necessarily identical to that of WKY rats (St Lezin et al., 1992).  
Thus far, rats with several different backgrounds have been used for 2VO model, including 
Sprague-Dawley, Wistar and WKY rats. There may therefore have been discrepancies between 
rats in terms of the temporal CBF profile after 2VO. The relative CBF reduction from the 
baseline level in the current study was smaller than that found in Sprague-Dawley or Wistar rats 
but approximated that of WKY rats (Farkas et al., 2007). 
The ameroid constrictor has been applied to the porcine or canine coronary arteries to 
simulate atherosclerotic coronary heart disease (Litvak et al., 1957), and the rabbit and rat 
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femoral arteries to mimic chronic hindlimb ischemia (Tang et al., 2005). However, this is the 
first report that the ameroid constrictor is applied to the CCA to replicate chronic cerebral 
hypoperfusion. Although the ameroid constrictor device achieves predictable gradual narrowing 
of the artery, the speed of arterial narrowing is dependent on both the size of ameroid constrictor 
and the diameter of arteries. As such, an in-vivo non-invasive imaging technique, such as CTA, 
may be applicable in the evaluation of the temporal change in carotid blood flow. Moreover, use 
of titanium for casing, instead of the stainless steel, will enable magnetic resonance 
imaging/angiography.  
Rats of 12–14 weeks of age were used in the current study to reproduce chronic cerebral 
hypoperfusion. However, application of the ameroid constrictor to older animals for longer 
period should be considered given that SIVD is an age-related disease that develops over many 
years. 
In conclusion, we have established a novel rat model that may more closely mimic 
cognitive impairment subsequent to selective white matter damage. The 2VGO model may 
therefore be adapted to explore possible treatments for SIVD. 
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A, Surgical implantation of the ameroid constrictor device on the right common carotid artery.  
B, Representative images of ameroid constrictors at indicated time points. 
C, Table showing the temporal profiles of stenosis of ameroid constrictor before surgical 
implantation (n=4) and 1 (n=8) and 3 days (n=4) post-operation. 
Figure 2. 
Experimental protocol (d=day and hr=hour). 
Figure 3. 
Three-dimensional volume-rendered images of CT-angiography showing the blood flow of the 
bilateral common carotid arteries pre- and post-implantation of ameroid constrictors at indicated 
time intervals. Arrowheads indicate common carotid arteries and arrows ameroid constrictors. 
Figure 4. 
A, Representative CBF images of laser speckle flowmetry in each group at indicated time 
intervals. The value in each image indicates relative CBF that is expressed as a percentage (± 
SEM) of the baseline level (100%). Four to six animals in each group were used at each point.  





F-FDG PET coronal images superimposed on MR images for the first 5 
minutes of the 2VGO (upper left panels) and 2VO (upper right panels) groups. Temporal 
profiles of the mean normalized 
18
F-FDG count during the first 5 minutes in the cerebral cortex 




F-FDG PET coronal images superimposed on MR images between 45 and 
90 minutes of the 2VGO (upper left panels) and 2VO (upper right panels) groups. Temporal 
profiles of the mean normalized 
18
F-FDG count between 45 and 90 minutes in the cerebral 
cortex (lower left), caudoputamen (lower middle) and hippocampus (lower right) at indicated 
time intervals. Three to four animals in each group were used at each point. * P<0.05, ** 
P<0.01, 2VGO vs. 2VO. † P<0.05, †† P<0.01, at each period in 2VO group vs. pre operation. 
Figure 6. 
A, B, Histogram showing spatial working memory impairment (A) and the locomotor activity 
(B) measured by Y-maze test at 28 days post-operation in the sham (n=10), 2VGO (n=11) and 
2VO (n=10) groups. 
Figure 7. 
A, Representative images of Klüver-Barrera staining in the corpus callosum at 28 days 
post-operation in each group (upper panels). Histogram showing the grading of the white matter 
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lesions in the sham (n=4), 2VGO (n=4) and 2VO (n=4) groups. Scale bar, 50 μm. 
B, Representative images of immunohistochemical staining for dMBP in the corpus callosum at 
28 days in each group (upper panels). Oligodendrocytic cell bodies of irregular size and myelin 
sheaths along the axons were densely stained for dMBP. Scale bar, 20 μm. Histogram showing 
the area fraction (%) of dMBP-immunopositive fibers in the sham (n=4), 2VGO (n=4) and 2VO 
(n=4) groups. 
C, Representative images of the immunohistochemical staining for glutathione S-transferase-pi 
(GST-π) in the corpus callosum at 28 days in each group (upper panels). Histogram showing the 
density of GST-π-immunopositive oligodendroglia in the sham (n=4), 2VGO (n=4) and 2VO 
(n=4) (lower panel) groups. Scale bar, 50 μm. 
Figure 8. 
Representative images of immunoblotting for MBP and β-actin in the optic nerve and chiasma 
of the sham (n=4), 2VGO (n=4), and 2VO (n=4) groups at 28 days post-operation. Histogram 
showing the relative amount of MBP as assessed by densitometric analysis. 
Figure 9. 
A, B, Histogram showing the mRNA levels of TNF-α (A) and MCP-1 (B), as analyzed with 
real-time RT-PCR, in the right anterior hemisphere of the sham (normalized as 1), 2VGO 
(18.7±7.28 and 2.79±1.02 fold, respectively), and 2VO (91.2±28.8 and 3.68±1.14 fold, 
 23 
respectively) groups at 1 day post-operation (n=4 in each group). 
C, Histogram showing the protein level of TNF-α, as analyzed with ELISA, in the left anterior 
hemisphere of the sham (8.38±0.63), 2VGO (16.0±2.70), and 2VO (20.8±2.67) groups at 1 day 
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